Overview
Takashi Akagi practices practicing medicine in Okayama, Japan.
His clinical expertise encompasses Chondrosarcoma, Chordoma, Intersex, and Osteosarcoma.
He is actively involved in clinical research, co-authoring 71 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Takashi Akagi
Is Takashi Akagi a top-rated expert for Chondrosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Takashi Akagi is classified as an Experienced expert for Chondrosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Takashi Akagi participate in research or clinical trials?
Yes. Takashi Akagi has published 71 articles and abstracts on conditions like Chondrosarcoma. You can view a list of Takashi Akagi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ChondrosarcomaMr. Akagi isExperienced. Learn about Chondrosarcoma.
- ChordomaMr. Akagi isExperienced. Learn about Chordoma.
- FibrosarcomaMr. Akagi isExperienced. Learn about Fibrosarcoma.
- IntersexMr. Akagi isExperienced. Learn about Intersex.
- OsteosarcomaMr. Akagi isExperienced. Learn about Osteosarcoma.